Circulating Human Papillomavirus DNA in Head and Neck Squamous Cell Carcinoma: Possible Applications and Future Directions.
Dauren AdilbaySaudamini LeleJohn PangAmeya AsarkarJason CalligasCherie Ann O NathanPublished in: Cancers (2022)
There has been a rising trend in HPV-induced head and neck cancers in the last several decades. This subgroup of squamous cell carcinoma is mostly located in the oropharynx and comprises a subset of patients who are typically younger and without the usual risk factors of smoking and alcohol use. As the prognosis of HPV-induced OPC is more favorable, there is a desire to properly select these patients for de-intensification protocols while identifying individuals who may suffer treatment failure. Here, we describe recent developments in circulating tumor HPV DNA as a marker of HPV-positive oropharyngeal cancer that can potentially be used as a diagnostic tool to stratify patients for de-escalation strategies and to survey for recurrence.
Keyphrases
- end stage renal disease
- circulating tumor
- squamous cell carcinoma
- chronic kidney disease
- ejection fraction
- newly diagnosed
- risk factors
- peritoneal dialysis
- high grade
- randomized controlled trial
- cell free
- oxidative stress
- single molecule
- clinical trial
- circulating tumor cells
- open label
- smoking cessation
- young adults
- squamous cell
- childhood cancer
- current status
- locally advanced
- double blind